Te-Hui Chou

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E

Shixia Wang, Ranajit Pal, John R. Mascola et al. · Virology · 2006 · 112 citations

Vaccination, Subtypes A, Vaccine Target +10

Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine

Shixia Wang, Diego J. Farfán-Arribas, Siyuan Shen et al. · Vaccine · 2005 · 103 citations

Vaccination, Codon Usage, Leader Sequence +12

Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1

Shixia Wang, James Arthos, Jean M. Lawrence et al. · Journal of Virology · 2005 · 100 citations · Full text

Immunology, Recombinant Dna, Subunit Protein +20

A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice

Chih‐Jen Wei, Wei Bu, Laura A. Nguyen et al. · Science Translational Medicine · 2022 · 93 citations · Full text

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

Shixia Wang, Destin W. Heilman, Fangjun Liu et al. · Vaccine · 2004 · 87 citations · Full text

Vaccination, Mucosal Vaccination, Lethal Mucosal Challenge +8